Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Ling

Showing results (81-90 of 164) with videos related to

Pageof 17
Sort By:
Addiction (Abingdon, England)|February 1, 2006
A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individualsRichard A Rawson, Michael J McCann, Frank Flammino, et al.
Drug and Alcohol Dependence|June 3, 2006
Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependenceKeith G Heinzerling, Steven Shoptaw, James A Peck, et al.
Drug and Alcohol Dependence|January 23, 2010
Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependenceKeith G Heinzerling, Aimee-Noelle Swanson, Soeun Kim, et al.
Substance Abuse and Rehabilitation|September 3, 2011
Co-occurring amphetamine use and associated medical and psychiatric comorbidity among opioid-dependent adults: results from the Clinical Trials NetworkDaniel J Pilowsky, Li-Tzy Wu, Bruce Burchett, et al.
Journal of Addiction Medicine|July 20, 2011
Pharmacokinetics of buprenorphine: a comparison of sublingual tablet versus liquid after chronic dosingPeggy Compton, Walter Ling, C Nora Chiang, et al.
Journal of Analytical Toxicology|November 11, 2003
Opiate recidivism in a drug-treatment program: comparison of hair and urine dataBradley K Charles, Jayme E Day, Douglas E Rollins, et al.
Journal of Substance Abuse Treatment|March 24, 2010
Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials NetworkJennifer Sharpe Potter, Amit Chakrabarti, Catherine P Domier, et al.
Obesity (Silver Spring, Md.)|July 20, 2007
Randomized controlled trials of the D1/D5 antagonist ecopipam for weight loss in obese subjectsArne Astrup, Frank L Greenway, Walter Ling, et al.
Pain|June 28, 2001
Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphineMark Doverty, Andrew A Somogyi, Jason M White, et al.
Journal of Ethnicity in Substance Abuse|May 29, 2010
Association of race and ethnicity with withdrawal symptoms, attrition, opioid use, and side-effects during buprenorphine therapyE Sherwood Brown, Carlos Tirado, Abu Minhajuddin, et al.
Pageof 17

Showing results (81-90 of 164) with videos related to

Sort By:
Pageof 17
Addiction (Abingdon, England)|February 1, 2006
A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individualsRichard A Rawson, Michael J McCann, Frank Flammino, et al.
Drug and Alcohol Dependence|June 3, 2006
Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependenceKeith G Heinzerling, Steven Shoptaw, James A Peck, et al.
Drug and Alcohol Dependence|January 23, 2010
Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependenceKeith G Heinzerling, Aimee-Noelle Swanson, Soeun Kim, et al.
Substance Abuse and Rehabilitation|September 3, 2011
Co-occurring amphetamine use and associated medical and psychiatric comorbidity among opioid-dependent adults: results from the Clinical Trials NetworkDaniel J Pilowsky, Li-Tzy Wu, Bruce Burchett, et al.
Journal of Addiction Medicine|July 20, 2011
Pharmacokinetics of buprenorphine: a comparison of sublingual tablet versus liquid after chronic dosingPeggy Compton, Walter Ling, C Nora Chiang, et al.
Journal of Analytical Toxicology|November 11, 2003
Opiate recidivism in a drug-treatment program: comparison of hair and urine dataBradley K Charles, Jayme E Day, Douglas E Rollins, et al.
Journal of Substance Abuse Treatment|March 24, 2010
Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials NetworkJennifer Sharpe Potter, Amit Chakrabarti, Catherine P Domier, et al.
Obesity (Silver Spring, Md.)|July 20, 2007
Randomized controlled trials of the D1/D5 antagonist ecopipam for weight loss in obese subjectsArne Astrup, Frank L Greenway, Walter Ling, et al.
Pain|June 28, 2001
Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphineMark Doverty, Andrew A Somogyi, Jason M White, et al.
Journal of Ethnicity in Substance Abuse|May 29, 2010
Association of race and ethnicity with withdrawal symptoms, attrition, opioid use, and side-effects during buprenorphine therapyE Sherwood Brown, Carlos Tirado, Abu Minhajuddin, et al.
Pageof 17